KPNA2 is upregulated in multiple kinds of malignancies and high KPNA2 level is associated with adverse outcome of patients with breast cancer [15], colorectal cancer (CRC) [16], and urothelial carcinoma [17] and so forth. This evidence concerns the gene KPNA2 and breast carcinoma.